Most ASX pharmaceuticals are small caps that are working on a medical treatment that they hope to bring to market. But a handful of companies have products out on the market. And the top stock (Blackmores) looks set to be delisted having accepted a takeover offer.
In this article, Stocks Down Under recaps 2 other well-positioned…
